Literature DB >> 26130510

Dangerous liaisons: cooperation between Pbx3, Meis1 and Hoxa9 in leukemia.

Ross M W Thorne1, Thomas A Milne2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26130510      PMCID： PMC4486217          DOI： 10.3324/haematol.2015.129932

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  24 in total

1.  The Hox cofactor and proto-oncogene Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver.

Authors:  J F DiMartino; L Selleri; D Traver; M T Firpo; J Rhee; R Warnke; S O'Gorman; I L Weissman; M L Cleary
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

2.  The HOX homeodomain proteins block CBP histone acetyltransferase activity.

Authors:  W F Shen; K Krishnan; H J Lawrence; C Largman
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

3.  Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.

Authors:  Bernd B Zeisig; Tom Milne; María-Paz García-Cuéllar; Silke Schreiner; Mary-Ellen Martin; Uta Fuchs; Arndt Borkhardt; Sumit K Chanda; John Walker; Richard Soden; Jay L Hess; Robert K Slany
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

4.  Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.

Authors:  Paul M Ayton; Michael L Cleary
Journal:  Genes Dev       Date:  2003-09-02       Impact factor: 11.361

5.  Pbx3 and Meis1 cooperate through multiple mechanisms to support Hox-induced murine leukemia.

Authors:  Maria-Paz Garcia-Cuellar; Julia Steger; Elisa Füller; Katrin Hetzner; Robert K Slany
Journal:  Haematologica       Date:  2015-04-24       Impact factor: 9.941

6.  Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny.

Authors:  Nicolas Pineault; Cheryl D Helgason; H Jeffrey Lawrence; R Keith Humphries
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

7.  Homeotic genes and the evolution of arthropods and chordates.

Authors:  S B Carroll
Journal:  Nature       Date:  1995-08-10       Impact factor: 49.962

8.  HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis.

Authors:  C A Schnabel; Y Jacobs; M L Cleary
Journal:  Oncogene       Date:  2000-02-03       Impact factor: 9.867

9.  Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias.

Authors:  T Nakamura; D A Largaespada; J D Shaughnessy; N A Jenkins; N G Copeland
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

10.  Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice.

Authors:  J J Moskow; F Bullrich; K Huebner; I O Daar; A M Buchberg
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272
View more
  5 in total

1.  Contribution of Caudal Müllerian Duct Mesenchyme to Prostate Development.

Authors:  Hannah Brechka; Erin M McAuley; Sophia M Lamperis; Gladell P Paner; Donald J Vander Griend
Journal:  Stem Cells Dev       Date:  2016-10-04       Impact factor: 3.272

2.  Higher expression levels of the HOXA9 gene, closely associated with MLL-PTD and EZH2 mutations, predict inferior outcome in acute myeloid leukemia.

Authors:  Li Gao; Junzhong Sun; Fang Liu; Hui Zhang; Yigai Ma
Journal:  Onco Targets Ther       Date:  2016-02-09       Impact factor: 4.147

3.  KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements.

Authors:  Yan Zi Au; Muxin Gu; Etienne De Braekeleer; Malgorzata Gozdecka; Demetrios Aspris; Yusuke Tarumoto; Jonathan Cooper; Jason Yu; Swee Hoe Ong; Xi Chen; Konstantinos Tzelepis; Brian J P Huntly; George Vassiliou; Kosuke Yusa
Journal:  Leukemia       Date:  2020-08-06       Impact factor: 11.528

4.  A genetic screen in Drosophila uncovers the multifaceted properties of the NUP98-HOXA9 oncogene.

Authors:  Gwenaëlle Gavory; Caroline Baril; Gino Laberge; Gawa Bidla; Surapong Koonpaew; Thomas Sonea; Guy Sauvageau; Marc Therrien
Journal:  PLoS Genet       Date:  2021-08-12       Impact factor: 5.917

Review 5.  MEIS1 and its potential as a cancer therapeutic target (Review).

Authors:  Maozhong Yao; Yong Gu; Zhaoxin Yang; Keyan Zhong; Zhanjuan Chen
Journal:  Int J Mol Med       Date:  2021-07-28       Impact factor: 4.101
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.